The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
What's more, the new painkiller doesn't include opioids like many painkillers currently on the market do. The FDA announced Thursday (Jan. 30) that it had approved the new class of prescription ...